(Q79811079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Wenzel U

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

374-376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315004%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002141

26 December 2019

exact match

0 references

cites work

Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Aldosterone blockade in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Aldosterone antagonism in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Use of aldosterone antagonists in resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Role of aldosterone in the remnant kidney model in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Receptor-mediated actions of renin and prorenin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002141

7 January 2021